Carlos Gil Moreira Ferreira is director of clinical research at the National Cancer Institute (INCA), where he currently works with research in lung cancer and the development of new drugs. Check out below a brief interview on the situation of targeted therapies today and where we are going with them.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)